Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903100-03-000433
Filing Date
2003-12-09
Accepted
2003-12-09 17:03:40
Documents
1
Period of Report
2003-12-08

Document Format Files

Seq Description Document Type Size
1 form3_cstewartex.html 3  
1 form3_cstewartex.xml 3 2315
  Complete submission text file 0000903100-03-000433.txt   4199
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Issuer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COLLAGENEX PHARMACEUTICALS INC 41 UNIVERSITY DR #200 NEWTOWN PA 18940
Business Address C/O COLLAGENEX PHARMACEUTICALS INC 41 UNIVERSITY DR. #200 NEWTOWN PA 18940 2155797388
STEWART COLIN W (Reporting) CIK: 0001272044 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28308 | Film No.: 031045309